India's Mid-Market May 2026: Fintech, Synbio, and Deeptech Series A/B Deals
Beyond the headline rounds, India's May 2026 mid-market spanned fintech (Sahi $33M), synthetic biology (StrainX $13M), B2B commerce, edtech, and precision manufacturing.
Beyond the headline rounds, India's May 2026 mid-market spanned fintech (Sahi $33M), synthetic biology (StrainX $13M), B2B commerce, edtech, and precision manufacturing.
European tech funding rebounded to €10.5B in May 2026 as mega-rounds powered a market recovery led by defense, deeptech, and sovereign technology.
May 2026 was the second-largest venture month on record — but strip out Anthropic's $50B and the real story is concentration, defense, and the reopening exit window.
D2C food brand Anveshan raised ₹121 crore (~$12.7M) Series B led by Vertex Ventures and IFC in May 2026, roughly doubling its valuation on a rural-sourcing model.
C2i Semiconductors raised a $16.7M Series A extension led by TDK Ventures and Peak XV in May 2026, advancing India's push into semiconductor design.
Corgi Insurance stacked a $160M Series B and a $106M Series B1 within weeks in May 2026, reaching a $2.6B valuation for its AI-native insurance platform.